Study identifier:D2287R00101
ClinicalTrials.gov identifier:NCT02640742
EudraCT identifier:N/A
CTIS identifier:N/A
Asthma Control, Quality of Life and Emotional Feelings in a Real Life Setting-A Cross-sectional Study of Adult Asthma Patients in Japan
asthma
N/A
No
-
All
1232
Observational
20 Years - 100 Years
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Oct 2017 by AstraZeneca
AstraZeneca
-
This study aims to evaluate the asthma control status, asthma symptoms (severity, frequency, and limitations on activities, etc.), QOL, and use of drugs for asthma attack in adult asthma patients.
Rationale for this Non-Interventional Study According to the Japanese Asthma Prevention and Management Guideline 2015 (Japan guideline (JGL) 2015), the goal in the management and treatment of asthma is “to be able to lead a life like a healthy individual.” In order to achieve this therapeutic goal, the achievement of “well-controlled” state based on the asthma control status is considered to be a clinical goal. However, there are few studies in which the asthma control status is accurately surveyed in a real life setting in adult asthma patients receiving continued treatment from physician in Japan and the actual situation is unknown. By understanding the status of asthma control in asthma patients in a real life setting, the clinical issues could be clarified. Therefore, such information would contribute to appropriate treatment of asthma. Thus, we planned this study to evaluate the asthma control status, asthma symptoms (severity, frequency, and limitations on activities, etc.), Quality of line (QOL), and use of drugs for asthma attack in the study population in a real life setting by recruiting patients through medical institutions providing continued care for asthma patients. Objectives of this Non-Interventional Study 1. Primary objective To assess the proportion of adult asthma patients receiving continued treatment from physician in Japan in each asthma control status defined by JGL 2015 (“poorly-controlled,” “insufficiently-controlled,” and “well-controlled”). 2. Secondary objectives To evaluate asthma symptoms (intensity, frequency, and limitations on activities, etc.), QOL, use of drugs for asthma attack, and emotional feelings in the study population; and to investigate the effects of demographic characteristics and pathologic properties of each patient on the status of asthma control, asthma symptoms, QOL, use of drugs for asthma attack, and emotional feelings.
Location
Location
Himeji, Hyogo, Japan, 672-8064
Location
Kobe, Hyogo, Japan, 650-0047
Location
Yanagawa, Fukuoka, Japan, 832-0059
Location
Fukuoka, koga, Japan, 811-3195
Location
Fukuoka, Fukuoka, Japan, 815-8588
Location
Kurume, Fukuoka, Japan, 830-0013
Location
Fukuoka, Fukuoka, Japan, 810-8539
Location
Shinjyuku-ku, Tokyo, Japan, 162-8655
Arms | Assigned Interventions |
---|
This information is not intended to replace the informed medical advice or medical treatments of a healthcare professional. Only a physician can determine if a specific medicine is the correct treatment for a particular patient. If you have questions regarding any information contained in this site, you must consult a suitably qualified healthcare professional. Before prescribing any AstraZeneca products, Healthcare Professionals should view their country specific information.